Roundhill GLP-1 & Weight Loss ETF Rating $25.83 -0.23 (-0.88%) As of 07/18/2025 03:08 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Roundhill GLP-1 & Weight Loss ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.OZEM Aggregate RatingModerate Buy 2.65Holdings in OZEM have an aggregate rating of Moderate Buy based on 390 analyst ratings issued in the past year covering 28 companies (140.7% of the portfolio).OZEM Aggregate Price Target$25.83High Prediction$25.83Average Prediction$25.83Low Prediction$25.83Holdings in OZEM have an aggregate price target of $25.83 and a range of $25.83 to $25.83 covering 28 companies (140.7% of the portfolio).OZEM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy10 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Roundhill GLP-1 & Weight Loss ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 28 OZEM Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings18.23%NVONovo Nordisk A/S$64.32-1.5%4.2499 of 5 stars2.27$112.00 74.1%11Positive News18.23%NVONovo Nordisk A/S$64.32-1.5%4.2499 of 5 stars2.27$112.00 74.1%11Positive News15.92%LLYEli Lilly and Company$771.78+1.3%4.9798 of 5 stars2.75$1,012.56 31.2%20Trending News15.92%LLYEli Lilly and Company$771.78+1.3%4.9798 of 5 stars2.75$1,012.56 31.2%20Trending News4.06%GPCRStructure Therapeutics$19.25-1.4%2.9488 of 5 stars3.00$76.17 295.7%7Positive NewsHigh Trading Volume4.06%GPCRStructure Therapeutics$19.25-1.4%2.9488 of 5 stars3.00$76.17 295.7%7Positive NewsHigh Trading Volume4.02%PFEPfizer$24.46-0.5%4.9618 of 5 stars2.45$28.55 16.7%22Trending News4.02%PFEPfizer$24.46-0.5%4.9618 of 5 stars2.45$28.55 16.7%22Trending News3.96%VKTXViking Therapeutics$32.01-0.2%4.637 of 5 stars3.00$87.15 172.3%14Positive NewsUpcoming Earnings3.96%VKTXViking Therapeutics$32.01-0.2%4.637 of 5 stars3.00$87.15 172.3%14Positive NewsUpcoming Earnings3.65%ALTAltimmune$4.08+0.7%2.2167 of 5 stars2.75$18.20 346.1%83.65%ALTAltimmune$4.08+0.7%2.2167 of 5 stars2.75$18.20 346.1%83.49%MTSRMetsera$42.71-3.6%N/A3.00$55.00 28.8%53.49%MTSRMetsera$42.71-3.6%N/A3.00$55.00 28.8%53.43%AZNAstraZeneca$68.79-0.7%3.8353 of 5 stars2.83$89.00 29.4%6Trending NewsAnalyst Revision3.43%AZNAstraZeneca$68.79-0.7%3.8353 of 5 stars2.83$89.00 29.4%6Trending NewsAnalyst Revision3.08%AMGNAmgen$294.76-1.2%4.3997 of 5 stars2.35$307.82 4.4%23Trending NewsAnalyst Revision3.08%AMGNAmgen$294.76-1.2%4.3997 of 5 stars2.35$307.82 4.4%23Trending NewsAnalyst Revision2.49%TERNTerns Pharmaceuticals$5.64+0.7%3.8634 of 5 stars2.60$15.63 177.0%52.49%TERNTerns Pharmaceuticals$5.64+0.7%3.8634 of 5 stars2.60$15.63 177.0%52.41%REGNRegeneron Pharmaceuticals$542.52-1.4%4.7754 of 5 stars2.80$814.57 50.1%252.41%REGNRegeneron Pharmaceuticals$542.52-1.4%4.7754 of 5 stars2.80$814.57 50.1%252.06%SRRKScholar Rock$40.72-5.0%3.0783 of 5 stars3.13$42.67 4.8%8Analyst ForecastInsider Trade2.06%SRRKScholar Rock$40.72-5.0%3.0783 of 5 stars3.13$42.67 4.8%8Analyst ForecastInsider Trade1.87%GILDGilead Sciences$108.22-0.5%4.8922 of 5 stars2.77$111.38 2.9%26Trending NewsInsider TradeAnalyst Revision1.87%GILDGilead Sciences$108.22-0.5%4.8922 of 5 stars2.77$111.38 2.9%26Trending NewsInsider TradeAnalyst Revision1.68%BHVNBiohaven$14.04-7.1%3.2275 of 5 stars3.07$58.46 316.4%15Trending News1.68%BHVNBiohaven$14.04-7.1%3.2275 of 5 stars3.07$58.46 316.4%15Trending News This page (NASDAQ:OZEM) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roundhill GLP-1 & Weight Loss ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Roundhill GLP-1 & Weight Loss ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OZEM Stock Alerts